Page last updated: 2024-09-05

sb 203580 and vk 19911

sb 203580 has been researched along with vk 19911 in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(vk 19911)
Trials
(vk 19911)
Recent Studies (post-2010) (vk 19911)
3,48941,137501

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)vk 19911 (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.1216
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.038
Mitogen-activated protein kinase 12Homo sapiens (human)0.1216
Mitogen-activated protein kinase 11Homo sapiens (human)0.1216
Mitogen-activated protein kinase 14Homo sapiens (human)0.1009

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JL; Boehm, JC; Bower, MJ; Gallagher, TF; Johnson, SR; Kassis, S1
Bellon, SF; Bemis, GW; Chen, G; Cochran, JE; Duffy, JP; Evindar, G; Ford, PJ; Galullo, VP; Gao, H; Germann, UA; Green, J; Harrington, EM; Huang, C; Jones, P; Murcko, MA; Pazhanisamy, S; Salituro, FG; Su, MS; Taslimi, P; Wang, YM; Wilson, KP1

Other Studies

2 other study(ies) available for sb 203580 and vk 19911

ArticleYear
Phenoxypyrimidine inhibitors of p38alpha kinase: synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.
    Bioorganic & medicinal chemistry letters, 2001, May-07, Volume: 11, Issue:9

    Topics: Enzyme Inhibitors; Mitogen-Activated Protein Kinases; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Phenols; Pyrimidines

2001
The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.
    ACS medicinal chemistry letters, 2011, Oct-13, Volume: 2, Issue:10

    Topics:

2011